Forty-seven percent of finance leaders plan to invest in technology to cut costs, but digital transformation has also come with obstacles, according to a recent report.
Category: Static
CUNY halts professor's Alzheimer's drug research amid investigation
After suspecting manipulated results in clinical trials for simufilam, an Alzheimer’s drug, by Hoau-Yan Wang, PhD, a neuroscience professor at the City College of New York, the City University of New York announced Oct. 27 it is conducting an investiga…
FDA approves new head and neck cancer drug
The FDA granted approval Oct. 27 for toripalimab-tpzi, a new drug therapy for head and neck cancer patients.
American Association of Critical-Care Nurses names chief clinical officer
Nationally-known patient safety expert Vicki Good, DNP, RN, has been selected by the American Association of Critical-Care Nurses as its next chief clinical officer.
Mississippi hospital taps former Ascension exec as chief nursing officer
Brenda Carroll, MSN, RN, has been named the chief nursing officer of Merit Health Wesley in Hattiesburg, Miss.
Ascension Via Christi to close Kansas ED
Ascension Via Christi on Dec. 20 will cease operations at its emergency department in Fort Scott, Kan., which has seen a steady decline in patient visits and its overall average daily census.
UNC Health chief nurse executive to retire
UNC Health’s chief nurse executive, Cathy Madigan, DNP, FN, will retire Nov. 17, the Chapel Hill, N.C.-based system said in a LinkedIn post.
Medical devicemaker reports 1 death, 10 injuries from surgical product
Olympus, a medical supply company based in Pennsylvania, warned customers that its High Flow Insufflation Unit may suddenly over-inflate air into a patient’s body without a warning. One death and 10 serious injuries have been reported to the FDA.
How CHS, Tenet, HCA and UHS fared in Q3
All four of the nation’s most prominent for-profit health systems have now reported third-quarter financial results. Here is a summary of some key numbers for Franklin, Tenn.-based Community Health Systems, Nashville, Tenn.-based HCA Healthcare, Dallas…
Drugmaker, CEO agree to pay up to $50M in false claims suit
Nostrum Laboratories and its founder and CEO, Nirmal Mulye, PhD, agreed to pay between $3.8 million and $50 million to settle allegations of underpaying Medicaid rebates.
